+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viscosupplementation - Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140110
The global market for Viscosupplementation was valued at US$5.6 Billion in 2024 and is projected to reach US$8.8 Billion by 2030, growing at a CAGR of 7.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Viscosupplementation market.

Global Viscosupplementation Market - Key Trends & Drivers Summarized

Why Is Viscosupplementation Becoming a Preferred Treatment for Osteoarthritis?

Viscosupplementation has emerged as a widely adopted, minimally invasive treatment for knee osteoarthritis (OA), providing pain relief and improved joint mobility for patients suffering from degenerative joint conditions. The procedure involves injecting hyaluronic acid (HA) into the synovial fluid, enhancing lubrication and reducing friction within the joint. With the rising prevalence of osteoarthritis, particularly among the aging population, viscosupplementation is being increasingly recommended as an alternative to pain medication and surgical interventions. Furthermore, the growing preference for non-surgical pain management solutions has led to heightened demand for HA-based injections across orthopedic clinics and hospitals.

How Are Technological Innovations Enhancing Viscosupplementation Therapies?

The viscosupplementation market is witnessing advancements in HA formulation, improving the efficacy and durability of treatment. Innovations such as cross-linked and high-molecular-weight HA injections have enhanced the viscosity and longevity of synovial fluid replacement, providing prolonged pain relief for osteoarthritis patients. Additionally, the development of single-injection therapies is gaining traction, reducing the need for multiple treatment sessions and improving patient compliance. Companies are also investing in novel drug-delivery systems and bioengineered HA derivatives to enhance treatment outcomes and minimize adverse effects.

What Are the Key Market Trends Shaping Viscosupplementation Adoption?

The increasing focus on early intervention and preventive healthcare is driving the adoption of viscosupplementation as a first-line treatment for knee osteoarthritis. Rising awareness about joint health and mobility preservation, especially among middle-aged individuals and athletes, is further fueling demand for HA injections. Additionally, the growing integration of regenerative medicine approaches, such as platelet-rich plasma (PRP) therapy in combination with HA injections, is expanding the therapeutic scope of viscosupplementation. Insurance coverage and reimbursement policies for osteoarthritis treatments are also evolving, making viscosupplementation more accessible to patients worldwide.

What Factors Drive the Growth of the Market?

The growth in the viscosupplementation market is driven by several factors, including the increasing prevalence of osteoarthritis, advancements in HA-based formulations, and the rising demand for non-surgical pain management solutions. The shift towards minimally invasive treatments is propelling the adoption of single-injection and cross-linked HA therapies. Additionally, improvements in healthcare infrastructure and expanding insurance coverage are making viscosupplementation more widely available. The integration of regenerative medicine techniques, coupled with increasing patient awareness of early-stage osteoarthritis management, is further contributing to market expansion.

Report Scope

The report analyzes the Viscosupplementation market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Segment (Single Injection, Three Injection, Five Injection).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Single Injection segment, which is expected to reach US$4.9 Billion by 2030 with a CAGR of a 8.5%. The Three Injection segment is also set to grow at 7.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.4 Billion in 2024, and China, forecasted to grow at an impressive 11.6% CAGR to reach $2.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Viscosupplementation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Viscosupplementation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Viscosupplementation Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Allergan PLC, Anika Therapeutics SRL, Contipro a.s., DePuy Synthes, F. Hoffmann-La Roche AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 46 companies featured in this Viscosupplementation market report include:

  • Allergan PLC
  • Anika Therapeutics SRL
  • Contipro a.s.
  • DePuy Synthes
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals, Inc.
  • Galderma SA
  • Lifecore Biomedical LLC
  • Merz Aesthetics
  • Mylan Pharmaceutical Pvt. Ltd.
  • Nordic Drugs
  • Sanofi SA
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • Smith & Nephew PLC
  • TRB Chemedica International SA

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Viscosupplementation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Osteoarthritis Driving Demand for Viscosupplementation Treatments
  • Growing Preference for Non-invasive and Minimally Invasive Pain Management Solutions
  • Advancements in Hyaluronic Acid Formulations Enhancing Viscosupplementation Efficacy
  • Increasing Adoption of Single-injection Viscosupplements for Patient Convenience
  • Expansion of Orthopedic Clinics and Sports Medicine Practices Boosting Market Growth
  • Surge in Awareness Campaigns Promoting Non-surgical Treatment Alternatives
  • Growing Use of Viscosupplementation in Joint Preservation and Pain Relief
  • Increasing Focus on Aging Population and Geriatric Healthcare Needs
  • Rising Availability of Customized Viscosupplement Products for Specific Joint Applications
  • Growing R&D Investments in Next-generation Viscosupplements with Longer-lasting Effects
  • Expansion of Direct-to-consumer Marketing and Online Product Availability
  • Increasing Adoption of Biodegradable and Natural Hyaluronic Acid Sources
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Single Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Single Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Single Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Three Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Three Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Three Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Five Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Five Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for Five Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 13: World Viscosupplementation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 15: USA Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 16: USA 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 19: Canada 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
JAPAN
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 22: Japan 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
CHINA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 24: China Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 25: China 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
EUROPE
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Viscosupplementation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 28: Europe 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 31: Europe 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
FRANCE
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 33: France Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 34: France 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
GERMANY
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 37: Germany 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 40: Italy 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 42: UK Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 43: UK 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 45: Spain Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 46: Spain 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 48: Russia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 49: Russia 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 52: Rest of Europe 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Viscosupplementation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 55: Asia-Pacific 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 58: Asia-Pacific 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
AUSTRALIA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • Table 59: Australia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 60: Australia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 61: Australia 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
INDIA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • Table 62: India Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 63: India Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 64: India 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
SOUTH KOREA
  • Table 65: South Korea Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 66: South Korea Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 67: South Korea 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
  • Table 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 69: Rest of Asia-Pacific Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 70: Rest of Asia-Pacific 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
LATIN AMERICA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • Table 71: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 72: Latin America Historic Review for Viscosupplementation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 73: Latin America 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • Table 74: Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 75: Latin America Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 76: Latin America 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
ARGENTINA
  • Table 77: Argentina Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 78: Argentina Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 79: Argentina 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
BRAZIL
  • Table 80: Brazil Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 81: Brazil Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 82: Brazil 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
MEXICO
  • Table 83: Mexico Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 84: Mexico Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 85: Mexico 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
  • Table 86: Rest of Latin America Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 87: Rest of Latin America Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 88: Rest of Latin America 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
MIDDLE EAST
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • Table 89: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 90: Middle East Historic Review for Viscosupplementation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 91: Middle East 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • Table 92: Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 93: Middle East Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 94: Middle East 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
IRAN
  • Table 95: Iran Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 96: Iran Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 97: Iran 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
ISRAEL
  • Table 98: Israel Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 99: Israel Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 100: Israel 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
SAUDI ARABIA
  • Table 101: Saudi Arabia Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 102: Saudi Arabia Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 103: Saudi Arabia 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
  • Table 104: UAE Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 105: UAE Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 106: UAE 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
  • Table 107: Rest of Middle East Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 108: Rest of Middle East Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 109: Rest of Middle East 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
AFRICA
  • Viscosupplementation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • Table 110: Africa Recent Past, Current & Future Analysis for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 111: Africa Historic Review for Viscosupplementation by Segment - Single Injection, Three Injection and Five Injection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 112: Africa 15-Year Perspective for Viscosupplementation by Segment - Percentage Breakdown of Value Sales for Single Injection, Three Injection and Five Injection for the Years 2015, 2025 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allergan PLC
  • Anika Therapeutics SRL
  • Contipro a.s.
  • DePuy Synthes
  • F. Hoffmann-La Roche AG
  • Ferring Pharmaceuticals, Inc.
  • Galderma SA
  • Lifecore Biomedical LLC
  • Merz Aesthetics
  • Mylan Pharmaceutical Pvt. Ltd.
  • Nordic Drugs
  • Sanofi SA
  • Shanghai Jingfeng Pharmaceutical Co., Ltd
  • Smith & Nephew PLC
  • TRB Chemedica International SA

Table Information